Senior Management and Board Update
23/07/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240723:nRSW3654Xa&default-theme=true
RNS Number : 3654X Alliance Pharma PLC 23 July 2024
For immediate release 23 July 2024
ALLIANCE PHARMA
("Alliance", "Company" or the "Group")
Senior Management and Board Update
Alliance Pharma plc (AIM: APH), the international healthcare group, announces
that Jeyan Heper, Chief Operating Officer ("COO"), will leave the business on
31 August 2024.
Jeyan Heper joined Alliance as COO and Board member on 1 February 2023,
helping to identify growth opportunities in international consumer healthcare
markets and supporting the Board and senior executive team to develop the
strategy for international markets, particularly China and the US.
In order to accelerate the globalisation of the business, to bring the
consumer closer to the heart of the business and to simplify the Company's
management structure, the Board has decided that the role of COO is no longer
a requirement at Alliance.
Nick Sedgwick, Chief Executive Officer of Alliance, said:
"I want to thank Jeyan for his contribution to Alliance, providing stability
and valuable international consumer healthcare insights as we continue on our
journey to transform to a high performing consumer healthcare company, built
on a portfolio of leading, trusted and proven brands. We wish him well in his
future endeavours."
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations & Corporate Communications + 44 (0)1249 705168
ir@allianceph.com (mailto:ir@allianceph.com)
Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills
alliancepharma@buchanan.uk.com (mailto:alliancepharma@buchanan.uk.com)
Deutsche Numis (Nominated Adviser and Joint Broker) + 44 (0)20 7260 1000
Freddie Barnfield / Duncan Monteith / Sher Shah
Investec Bank plc (Joint Broker) + 44 (0)20 7597 5970
Patrick Robb / Maria Gomez de Olea
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare group. Our
purpose is to improve the lives of consumers and patients through making
available a range of clinically valuable healthcare products.
Our core focus is on the marketing of Consumer Healthcare brands, complemented
by a smaller Prescription Medicines business. In total, we hold marketing
rights to around 80 brands, with revenues generated from a mix of direct,
distributor and e-commerce sales.
Headquartered in the UK, the Group employs around 290 people based in
locations across Europe, North America, and the Asia Pacific region. By
outsourcing our manufacturing and logistics operations, we remain asset-light
and focused on maximising the value of our brands.
For more information on Alliance, please visit our
website: www.alliancepharmaceuticals.com
(http://www.alliancepharmaceuticals.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOASEAFWEELSEIW